Sands Capital Ventures

Sands Capital Ventures is a venture firm committed to identifying highly innovative businesses - companies and individuals that have the capacity to transform a given industry. We are passionate about innovation, technology, and entrepreneurship and we want to join you in profitably transforming humanity. We look forward to working with you.

Andrew P. Giordano

Senior Director of Client Relations

124 past transactions

eXo Systems

Series C in 2021
Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes. The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.

Hungry Marketplace

Series C in 2021
Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.

Allvision IO, Inc.

Seed Round in 2019
Allvision IO, Inc. develops platform that aggregates multiple sources of 3 dimensional data. The platform backed by machine learning and cloud computing provides analysis to derive actionable information. Allvision IO, Inc. provides asset detection and tracking; mobility maps; and compliance information to users. It caters to transportation, engineering, infrastructure, government, and insurance industry. The company was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.

Totient

Seed Round in 2020
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

Blackbuck

Series C in 2017
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

Upgrade Inc.

Series F in 2021
Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

UiPath

Series D in 2019
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

WireWheel.io

Series A in 2018
WireWheel, Inc. develops a data privacy management platform that helps comply with data privacy and data protection regulations. The company’s platform complies with regulations, including the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Its products include privacy program management and subject rights request management. The company combines machine learning, data science, and cloud computing. WireWheel, Inc. was incorporated in 2016 and is based in Arlington, Virginia

Avitide, Inc.

Series E in 2017
Avitide, Inc. discovers, manufactures, and supplies molecule-specific affinity purification solutions for the biopharmaceutical industry. It offers affinity separation technology that enables customers to achieve bioprocess development timelines, reduce program risk, predict commercial scalability, and reduce manufacturing costs. The company also develops affinity purification solutions for the manufacturing of life-saving therapeutics, including enzymes, novel scaffolds, multi-specific antibodies, gene therapies, and vaccines. Avitide, Inc. was incorporated in 2012 and is based in Lebanon, New Hampshire.

Health Catalyst

Series D in 2015
Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

Acrivon Therapeutics

Series B in 2021
Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success.

Primer

Series C in 2021
Primer Technologies, Inc. develops software that uses machine learning techniques to help parse and collate a large number of documents across several languages. The company's systems read documents, discover insights, and automatically generate reports comparable to those of a human analyst. It helps governments and corporations monitor and understand the world’s information. Primer Technologies, Inc. was incorporated in 2014 and is based in San Francisco, California.

LimaCharlie

Seed Round in 2022
Security Infrastructure as a Service (SIaaS). LimaCharlie abstracts away the hard parts of information security and delivers them on-demand (or à la carte) at scale in a manner similar to any major cloud provider drastically reducing costs and effort. We supply all the tools to run an MSSP or SOC as well as providing API’s that allow users to build and monetize their own products.

Samumed

Venture Round in 2021
Samumed, LLC is engaged in small molecule drug development using assays and screens for the treatment of oncology and degenerative diseases. Its product includes SM04690, a small molecule inhibitor of the Wnt pathway that is administered as an intra-articular injection for treatment of osteoarthritis of the knee; and SM07883, a small-molecule designed to reduce disease pathology. The company was known as Wintherix & Epitherix, LLC. Samumed, LLC was founded in 2007 and is based in San Diego, California.

Mekonos Inc.

Series A in 2021
Mekonos Inc. engages in the design, development, and production of gene and cell therapies. The company develops integrated system-on-a-chip to develop predictive models for discovery and development. It develops MEMS, a technology that allows controlling individual nanoneedles to inject single cells, in a parallel architecture. Also, the company operates a cell-engineering platform. The company was founded in 2017 and is based in San Francisco, California

Scopely

Series A in 2014
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Vesper

Series B in 2018
Vesper Technologies Inc. develops and manufactures piezoelectric MEMS microphones. It offers its products for various microphone array applications in mobile handsets, tablets, and other products. The company was formerly known as Sonify. The company was founded in 2009 and is based in Boston, Massachusetts.
Acumen Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics and diagnostics for treating Alzheimer’s disease and related neurodegenerative conditions. The company focuses on developing ADDL-Select antibodies that target soluble Aß oligomers, which are main causes in the disease process. It also uses a sensitivity assay to measure soluble Aß oligomer levels in the cerebrospinal fluid in patients to be enrolled in clinical trials. Acumen Pharmaceuticals, Inc. was founded in 1996 and is based in Livermore, California.

Nubank

Series G in 2021
Nubank issues, administrate, processes, and transfers payments related to post-paid credit cards and equity investment in other entities. It serves clients in Brazil. The company launched its proprietary loyalty rewards program ("Nubank Rewards"), as well as a digital account ("NuConta") that is already used by more than 17 million people. In Cristina Junqueira, David Velez, and Edward Wible founded EO2 Solucoes de Pagamento on May 6, 2013 that became Nubank in on June 25, 2013. It has its headquarters in São Paulo in Brazil.

Qvella Corporation

Venture Round in 2021
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Qvella Corporation

Venture Round in 2019
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Redbud Brands

Venture Round in 2022
RedBud Brands is a brand development studio bringing people, ideas, and capital together to create disruptive new companies with an emphasis on the consumer space. It is an innovative venture platform for launching impactful brands that partners with visionary founders and executives to support and supercharge the creation of transformative, valuable, and sustainable companies. The company focuses primarily on premium, consumer packaged goods sectors with an emphasis on 'better-for-you' products.
Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Their specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Their suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. They also offer products designed specifically for ambulatory surgery centers.

Rgenix, Inc.

Series D in 2022
Rgenix is a a discovery platform, revolutionizing the treatment of cancer by generating the first-in-class therapeutics that target key nodes in cancer progression. Its proprietary discovery platform is based on innovations in cancer biology that enable the identification and validation of novel post-transcriptionally regulated targets. Rgenix’s productive approach has yielded multiple novel targets to date across several cancer types for which the company is developing drugs, and its scientific approach has led to the discovery of novel therapeutic targets and first-in-class drugs for several cancer subtypes, including melanoma, colorectal cancer, and triple-negative breast cancer, among others. Its aim is to discover and develop safe, effective, and commercially viable therapies that will transform the lives of cancer patients by treating metastatic disease.

Scopely

Series D in 2019
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

SafeBreach

Series D in 2021
SafeBreach is a pioneer in the emerging category of breach and attack simulation. The company's groundbreaking platform provides a “hacker's view” of an enterprise’s security posture to proactively predict attacks, validate security controls and improve SOC analyst response. SafeBreach automatically executes breach methods with an extensive and growing Hacker’s Playbook of research and real-world investigative data. SafeBreach is funded by Sequoia Capital, Deutsche Telekom Capital, Hewlett Packard Pathfinder and investor Shlomo Kramer.

Uhnder Inc.

Series A in 2017
Uhnder is a start-up developing products for sensing, cognition, and communication for the Internet of Things (IoT) market. It is headquartered in California with engineering and operations based in Austin and St. Louis. Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response. Uhnder disrupts the autonomous vehicle business with what it says is a more accurate and reliable alternative to light detection and ranging, known as lidar, which is one of the most common technologies used to make vehicles more aware of their surroundings. Uhnder's chip helps to avoid collisions, alerts to potential problems, helps with quick localization, as electronic fences for navigation and localization and for communication.

Blackbuck

Series E in 2021
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

Day Zero Diagnostics Inc.

Venture Round in 2022
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.
Modernizing Medicine® and its affiliated companies are transforming how healthcare information is created, consumed and utilized in order to increase practice efficiency and improve patient outcomes. Their specialty-specific, data-driven and cloud-based electronic health records (EHR) and practice management (PM) systems, plus revenue cycle management (RCM) services, were built by a team including specialty physicians and practice management professionals. Their suite of products and services is designed to transform the clinical, financial and operational aspects of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices. They also offer products designed specifically for ambulatory surgery centers.

Speech Graphics Ltd

Series A in 2022
Speech Graphics Ltd provides procedural facial animation solutions to the entertainment industry. The company offers SGX, a production software solution that processes audio files and transcripts into facial animation. Its animations feature in various productions ranging from AAA video games to music videos, and are used in communication, training, and more. The company was founded in 2010 and is based in Edinburgh, United Kingdom.

Prilenia

Series B in 2021
Prilenia Therapeutics B.V., a clinical stage biotech company, researches and develops products for movement disorders and neurodegenerative diseases affecting adults and children. It offers Pridopidine, an orally bioavailable small molecule investigational drug for huntington disease, amyotrophic lateral sclerosis, Parkinson’s disease levodopa induced dyskinesia, neurodegenerative eye disease, Parkinson’s disease, rett syndrome, fragile X, and Alzheimer’s disease. The company was founded in 2018 and is based in the Netherlands.

Freenome, Inc.

Series D in 2021
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Snyk

Series F in 2021
Snyk enables users to detect, fix, and prevent known vulnerabilities in third-party code modules, including Node

Bridgit Inc.

Series B in 2021
Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Blackbuck

Series D in 2018
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

JumpCloud

Series F in 2021
JumpCloud enables IT to securely manage user identities and connect them to resources regardless of provider, protocol, vendor, or location. JumpCloud is the first Directory-as-a-Service (DaaS), Active Directory, and LDAP reimagined. It centralizes and simplifies identity management and gives users one set of credentials to securely access their systems, apps, networks, and file servers – regardless of platform, protocol, provider, or location.

FraudScope, Inc.

Series B in 2022
FraudScope, Inc. develops artificial intelligence (AI) based platform for healthcare fraud, waste, and abuse applications. It offers FraudScope, a software platform to detect, score, and rank suspect medical billing practices; and augment existing methodologies using sophisticated algorithm tuning to detect fraud schemes in raw claims data. The company’s platform also scans medical insurance claims data and creates real-time profiles for each provider, provider type, beneficiary, diagnosis, service profile, and care pathway; aggregates substantiated evidence for the fraud it detects; and ensures that healthcare dollars go to real patient care. FraudScope, Inc. was founded in 2016 and is based in Atlanta, Georgia.

Vesper

Venture Round in 2021
Vesper Technologies Inc. develops and manufactures piezoelectric MEMS microphones. It offers its products for various microphone array applications in mobile handsets, tablets, and other products. The company was formerly known as Sonify. The company was founded in 2009 and is based in Boston, Massachusetts.

BigBasket

Series E in 2017
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.

SafeRide, Inc

Series B in 2021
SafeRide focuses on providing patients with transportation services to attend their health appointments in time. SafeRide provides healthcare providers with solutions to send text alerts about appointments and track the rides of their patients. SafeRide was founded by Whit Schrader and Robbins Schrader in April 2015.

Nucleix Ltd.

Venture Round in 2022
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.

paid

Series B in 2021
Learn more about #paid’s creator media platform at www.hashtagpaid.com/product

Gusto

Series E in 2021
Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resource, and integration services for employers and employees in the United States. Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuter benefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services. Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.

Qvella Corporation

Venture Round in 2020
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

RayzeBio

Series D in 2022
RayzeBio, Inc. is a biotechnology company that develops tumor-targeted small molecule medicines that harness the power of radioisotopes. The company provides macrocyclic peptide mimetic binders to deliver therapeutic radioisotopes, such as Actinium-225, an alpha-emitter for solid tumors. RayzeBio, Inc. was founded in 2020 and is based in San Diego, California.

Paydiant, Inc.

Series B in 2012
Paydiant, Inc. provides a cloud-based white label mobile wallet platform. The company’s platform enables merchants, banks, and partners to integrate mobile payments, offers, loyalty, and ATM cash access into their own branded mobile app. It offers its solutions through resellers and distributors. The company was incorporated in 2010 and is based in Auburndale, Massachusetts. As of April 2, 2015, Paydiant, Inc. operates as a subsidiary of PayPal Holdings, Inc.

Klaviyo, Inc.

Series D in 2021
Klaviyo, Inc. provides an email marketing software. It offers Klaviyo, an email marketing software that features a best practice emails library, segmentation tools, newsletters, analytics and ROI reports, customer profiles, administration tools, APIs, drip campaigns, abandoned carts, sign up forms and list growth, and others. Klaviyo, Inc. was founded in 2012 and is headquartered in Boston, Massachusetts with an additional office in London, United Kingdom.

DiCE Molecules Corp

Series C in 2021
DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.
Acumen Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics and diagnostics for treating Alzheimer’s disease and related neurodegenerative conditions. The company focuses on developing ADDL-Select antibodies that target soluble Aß oligomers, which are main causes in the disease process. It also uses a sensitivity assay to measure soluble Aß oligomer levels in the cerebrospinal fluid in patients to be enrolled in clinical trials. Acumen Pharmaceuticals, Inc. was founded in 1996 and is based in Livermore, California.

Boom Fantasy

Venture Round in 2021
Boom Sports is a technology company whose mission is to entertain and connect sports fans through games. After building the most popular real-money pick 'em daily fantasy product (2-time EGR app of the year), we're designing and operating world-class, free-to-play, games for media, league, and pro sports team partners. Our flagship product is NBC Sports Predictor, which offers fans in all 50 states the chance to win real money based on their (free) predictions. The product has been a huge success -- hundreds of thousands of active users, a 4.8 app store rating on 2K+ reviews -- and has provided a model for others that want to maximize the value of their audience in advance of legalized sports betting. If you want to build (legal) sports gaming products for the next generation of fans, come join us! We're hiring!

DiCE Molecules Corp

Series C in 2021
DiCE Molecules Corp. develops a transformative platform for the discovery of novel small molecules directed against previously intractable targets in the pharmaceutical industry. Its technology allows the extension of directed evolution to provide organic compounds as the output. The company also develops a methodology for translating DNA encoded information directly into organic compounds in essence roboticizing the laborious processes of medicinal chemistry. Its technology is used in the fields of pharmaceuticals, agriculture, and materials sciences. DiCE Molecules Corp. was incorporated in 2013 and is based in Menlo Park, California.

Tellius

Series A in 2021
Tomorrow's Insights Today: Spend less time on reporting and more time on executing. We built Tellius to make big data simple for the modern workforce. Cut through swathes of information and find the answers you’re looking for whether you’re an IT pro, marketing guru or C-level exec. Tellius extends traditional self-service BI concepts through the use search-enabled visualizations and a proprietary recommendation engine that automates the basic interpretation and analysis of data. Using machine learning, Tellius analyzes data to find hidden correlations, trends and anomalies which are then presented as a set of suggested visualizations and predictive models. Unlike traditional BI tools, Tellius is built on a distributed architecture (Apache Spark) which provides the scale and performance required for Big Data environments.

Poly AI

Series A in 2021
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.

MuleSoft

Series G in 2015
MuleSoft makes it easy to connect the world’s applications, data, and devices. They provide a software platform that enables organizations to easily build application networks using APIs. APIs are the digital glue that allows applications to talk to each other and exchange data. Their flexible, unified platform connects nearly any application or system by leveraging APIs to quickly and securely share data, regardless of format or source, in application networks. It was founded in 2006 and is headquartered in San Francisco, California,.

Kidaptive

Seed Round in 2012
Kidaptive, Inc. develops interactive educational content for preschoolers. The company's products include Leo's Pad, a series of interactive educational applications for children and Parent's Pad, a built-in assessment tool for parents; Adaptive Learning Platform (ALP) brings together observations from across contexts, which include tiles in mosaic, producing a detailed picture of that learner progress and preferences. Kidaptive, Inc. was founded in 2011 and is based in Redwood City, California.

DocuSign

Series E in 2014
DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

Opinio

Seed Round in 2015
Opinio is a fast growing start-up that builds next generation last mile delivery service for food, grocery, bakery, peer-to-Peer and more. Founded by IIT Kanpur Computer Science graduates, company started its operations on 15th of June, 2015. They recently got funded by India's biggest VC firm, Accel Partners (Portfolio Companies: Facebook, Flipkart, Myntra etc.) Operating on a B2B model, they partner with local merchants to help them deliver goods to the customer through our fast expanding fleet of Ground Pilot's.

Complete Genomics

Series E in 2010
Complete Genomics' high quality, affordable DNA sequencing enables commercial-scale research of the genetic mechanisms underlying drug responses and complex diseases. Complete Genomics combines innovative technology with a disruptive market approach that will revolutionize DNA sequencing.

Kit Check

Series A in 2013
KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Check product streamlines recording, waste reconciliation, and billing for medications used in the operating room. Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked.

BrightFlag

Series A in 2019
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.

Qvella Corporation

Series B in 2017
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Poly AI

Series A in 2019
PolyAI is a London-based company that develops a machine learning platform for conversational artificial intelligence.

Funding Circle Limited

Series F in 2017
When Funding Circle was founded, they could see that businesses weren’t being given the finance to grow, while investors were making poor returns. They had a simple idea — let them support each other. By lending directly to businesses through Funding Circle, investors can now earn attractive returns to better provide for their future. Businesses get fast, easy access to funding to grow, create jobs, support local communities and drive the economy forward. They believe it’s better for everyone.

BYJU’S

Private Equity Round in 2020
BYJU’S is a valuable ed-tech company at USD 10.5 billion and the creator of India’s most loved school learning app which offers highly adaptive, engaging, and effective learning programs for students in classes 1 -12 and competitive exams like JEE, NEET, CAT, and IAS. BYJU'S launched its flagship product, BYJU’S - The Learning App, for classes 4-12 in 2015. Today, the app has over 42 million registered students. With an average time of 71 minutes being spent by a student on the app every day from 1700+ cities, the app is creating a whole new way of learning through visual lessons. The Disney. BYJU'S Early Learn App was launched in June 2019, a special offering from BYJU'S for students in classes 1-3 featuring Disney’s timeliness characters. In early 2019, BYJU'S also acquired Osmo, a Palo Alto-based maker of educational games to transform the whole offline to an online learning experience.

UiPath

Series D in 2019
UiPath designs and develops robotic process automation software. The platform offers foolproof development tools, automation of intricate processes, enhanced control, cloud and on-premise deployment, robust governance, and multiple robots on a single virtual machine. UiPath also provides UiPath Studio that models automation visually, UiPath Orchestrator that manages critical enterprise duties, and UiPath Robot that executes processes. It caters to finance and banking, insurance, healthcare, telecom, manufacturing, BPOs, and shared service organizations. Daniel Dines and Marius Tirca founded UiPath in 2005, with its headquarters in New York City. It has additional offices in London in the United Kingdom, Paris in France, Bucharest in Romania, Tokyo in Japan, Singapore, Bengaluru in India, and Melbourne in Australia.

908 Devices Inc.

Series E in 2019
908 Devices is bringing the powerful capabilities of Mass Spectrometry out of the confines of centralized facilities and mobile laboratories. The company makes battery-operated, handheld, chemical detection tools, rugged enough to exceed military standards, and trusted enough for immediate action in the field. For biologists and chemists in need of answers, 908 Devices makes personal analyzers, small and simple enough for every workspace.
Neptune Financial (NepFin) is a next-generation financial services company whose commercial lending platform provides growth capital to mid-sized American businesses. With its team's experience in technology, traditional leveraged finance, and online lending, the company is poised to transform the way that middle-market borrowers access debt financing. Based in San Francisco, NepFin is supported by the same early investors as SoFi, Funding Circle, Lending Club and Upgrade. For more information please visit www.nepfin.com.

Freenome, Inc.

Series C in 2020
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Mitra Biotech

Series B in 2016
Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

Totient

Seed Round in 2020
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.

Karuna Pharmaceuticals

Series B in 2019
Karuna Pharmaceuticals, Inc. engages in development of drugs for the treatment of schizophrenia. The company was incorporated in 2009 and is based in Boston, Massachusetts.

NanoView Diagnostics Inc.

Series B in 2018
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.

Stipple

Venture Round in 2012
Stipple is the future of the visual web where the web's biggest asset, digital images, transform into experiences that drive discovery, engagement, purchase, and loyalty in-image. Stipple’s image-based marketing technology stack detects, recognizes, and identifies the content inside images at scale and enables Advertisers and Publishers to apply interactive curated content, accurate native advertising solutions, and connects organically to commerce. Only Stipple's marketing technology offers image analytics, advertising & messaging inside images web-wide and without widgets or embed code at scale. Stipple is based in San Francisco and funded by Floodgate, Kleiner Perkins, Relevance Capital and a syndicate of prominent early-stage investors.

BigBasket

Venture Round in 2017
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.

Health Catalyst

Series F in 2019
Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

Mitra Biotech

Series C in 2018
Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.

Teckro, Inc.

Series B in 2017
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.

Kit Check

Series C in 2016
KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Check product streamlines recording, waste reconciliation, and billing for medications used in the operating room. Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked.

Blackbuck

Series D in 2019
Keeping technology at the core, Zinka Logistics is redefining the logistics landscape of India, making it reliable and efficient. Our comprehensive approach to problems creates impact on the entire ecosystem of transportation, which stitches across large number of livelihoods. The transportation sector is ripe for a revolution, and Zinka Logistics marks the beginning.

DoorDash

Series G in 2019
DoorDash, Inc. operates a logistics platform that connects merchants, consumers, and dashers in the United States and internationally. It operates DoorDash marketplace, which provides an array of services that enable merchants to solve mission-critical challenges, such as customer acquisition, delivery, insights and analytics, merchandising, payment processing, and customer support; and offers DoorDash Drive, a white-label logistics service. The company was formerly known as Palo Alto Delivery Inc. and changed its name to DoorDash, Inc. in 2015. DoorDash, Inc. was founded in 2013 and is headquartered in San Francisco, California.

Slack Fund

Series H in 2018
Slack Technologies, Inc. operates Slack, a business technology software platform in the United States and internationally. Its platform brings together people, applications, and data, as well as sells its offering under a software-as-a-service model. The company was formerly known as Tiny Speck, Inc. and changed its name to Slack Technologies, Inc. in 2014. Slack Technologies, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

Bridgit Inc.

Series A in 2019
Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Upgrade Inc.

Series A in 2017
Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

Zaarly

Series A in 2011
Zaarly, Inc. operates as an online marketplace for small business owners who provide customer services. It provides services for home owners in Denver, Minneapolis, Kansas City, and Northern Virginia. The company was founded in 2011 and is based in San Francisco, California.

Quad Technologies

Series A in 2015
Quad Technologies is disrupting cell separation and cell therapy workflows by providing researchers with a simple, cell-friendly capture and release technology for cell isolation. Their new MagCloudz™ Streptavidin Cell Separation kit, featuring novel QuickGel™ technology platform, enables straightforward, scalable and fast cell separation with unique magnetic particle dissociation, resulting in complete label free cells. For applications such as T Cell purification, stem cell isolation, circulating tumor cell (CTC) separation and immunotherapy, this unique solution offers drastically improved cell viability, purity and recovery while maintaining a native cellular phenotype.

Funding Circle Limited

Series E in 2015
When Funding Circle was founded, they could see that businesses weren’t being given the finance to grow, while investors were making poor returns. They had a simple idea — let them support each other. By lending directly to businesses through Funding Circle, investors can now earn attractive returns to better provide for their future. Businesses get fast, easy access to funding to grow, create jobs, support local communities and drive the economy forward. They believe it’s better for everyone.

Genometry, Inc.

Series A in 2012
Genometry, Inc. operates as a platform-technology company that gene-expression profiling solutions for pharmaceutical discovery applications. It produces gene-expression profiles from crude cell lysates in well plate format. The company’s biomedical-research community also engages in drug-discovery activities. It offers data-generation and primary analysis solutions to the pharmaceutical and biotechnology industries, non-profit organizations, and academic researchers. Genometry, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

DocuSign

Series F in 2015
DocuSign, Inc. provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals. The company was 2003 and is headquartered in San Francisco, California.

Betable

Series A in 2013
Betable is the world’s first platform that enables any developer to legally offer real-money play in their games and apps on any platform or device. Betable is licensed by the United Kingdom Gambling Commission and Alderney Gambling Control Commission to offer support and infrastructure to developers to legally integrate real-money gambling into their mobile and social games and applications. Betable provides world-leading security, fraud protection, player location, identity and age verification and account monitoring to keep players’ funds safe and to ensure responsible gaming. Betable was founded in 2008 in London, United Kingdom. It also is headquartered in San Francisco, California.

Hungry Marketplace

Series A in 2019
Hungry Marketplace, Inc. operates a mobile food marketplace that connects foodies with local chefs. The company offers HUNGRY, a marketplace that allows user to search and order made-to-order meals prepared by local chefs. It delivers fresh-cooked meals to foodies across District of Columbia, Maryland, and Virginia. The company was founded in 2016 and is based in Arlington, Virginia.

Qvella Corporation

Series A in 2015
Qvella is a molecular diagnostics company founded in 2009 by a group of scientists and engineers with the primary goal of dramatically reducing time to results in microbiology. This objective, widely recognized as highly desirable, has proved elusive yet holds the promise of revolutionizing how medicine is practiced by offering actionable results in clinically relevant time frames to improve patient outcomes and save lives. Qvella's Field Activated Sample Treatment (FAST™) technology utilizes a novel electrical lysing and sample treatment technique we call e-lysis™; enabling direct and fully-automated rapid detection of infectious agents from unenriched biological samples.

Teckro, Inc.

Series C in 2019
Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company facilitates connections between investigators and the expertise they need; and helps study teams, sites, and patients to connect. Its solution instantly captures and shares team’s knowledge to dramatically reduce the burden on CRAs, medical monitors, data management, and study personnel. The company serves pharmaceutical companies and clinical researchers across the world. Teckro, Inc. was incorporated in 2015 and is based in Limerick, Ireland.

Anaplan

Series D in 2014
Anaplan is driving a new age of connected planning. Large and fast-growing organizations use Anaplan’s cloud platform in every business function to make better-informed plans and decisions and drive faster, more effective planning processes. Anaplan also provides support, training, and planning transformation advisory services. Anaplan is a privately held company based in San Francisco with 16 offices and over 150 expert partners worldwide. To learn more, visit anaplan.com.

Earli

Series A in 2021
Earli’s mission is to make cancer a benign experience, by making it possible to locate cancer that is detected early, so it can actually also be treated early when the chances of survival are highest. Earli is creating the new category of Synthetic Biopsies to force cancer cells to produce a non-human synthetic biomarker that can make tumors visible that are usually to early to discern. The platform is also usable for therapeutics.

SeLux Diagnostics

Series B in 2018
SeLux Diagnostics, Inc. develops a next generation phenotyping platform for antibiotic susceptibility testing and diagnostics of infectious disease. It develops a synthetic amplifier technology equipment that breaks the speed versus complexity tradeoff in AST testing and dramatically improves patient care. SeLux Diagnostics, Inc. was founded in 2014 and is based in Charlestown, Massachusetts.

DataRobot

Series E in 2019
DataRobot delivers AI technology and ROI enablement services to global enterprises competing in today’s intelligence revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. The company was founded in 2012 and is headquartered in Boston, Massachusetts.

Taysha Gene Therapies

Series B in 2020
Taysha Gene Therapies is a developer of treatments to eradicate severe & life-threatening monogenic diseases of the central nervous system. Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we are able to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications.

Day Zero Diagnostics Inc.

Seed Round in 2017
Day Zero Diagnostics (DZD) is developing a new class of diagnostic that enables a physician to switch from broad spectrum antibiotic therapy to a targeted antibiotic in 5 hours rather than the 2-5 days that it typically takes today. Unlike other molecular diagnostics that can only detect a handful of specific targets, DZD uses the entire genomic sequence and our proprietary Keynome™ algorithm to identify a comprehensive range of bacterial pathogens and their resistance characteristics within hours.

BigBasket

Series E in 2018
BigBasket is an online food and grocery store that delivers personal and household needs right to customers' doorstep. The company believes in being smart, quick, and efficient making life as leisurely as possible. Customers can browse through the vast range of products at bigbasket.com, order, and get them to be delivered at the customers' own convenient time slot. The company handpicks each and every product, putting it through a safety packaging process, and delivering to customers' home.

Scopely

Seed Round in 2012
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Lending Club

Private Equity Round in 2014
Lending Club is an online financial community that brings together creditworthy borrowers and savvy investors so that both can benefit financially. They replace the high cost and complexity of bank lending with a faster, smarter way to borrow and invest. Founded in 2007, the company is headquartered in San Francisco, California, United States.

Health Catalyst

Debt Financing in 2019
Catalyst is solving healthcare data warehouse issues for some of the nation’s top health systems. With the shift from paper to electronic records, it has become a challenge to organize health data, make sense of it, and to do it quickly. Catalyst helps organize, normalize, and link the data from all different systems. And they make it searchable by all users, even the non-technical, by using rich metadata capabilities.

Scopely

Series C in 2017
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

Kit Check

Series B in 2015
KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Check product streamlines recording, waste reconciliation, and billing for medications used in the operating room. Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked.

Upgrade Inc.

Series C in 2018
Upgrade is a neobank that offers credit to mainstream consumers through cards and personal loans, together with free credit monitoring and education tools that help consumers understand and manage their finances. Upgrade Card provides an innovative credit card that brings the low cost and responsible credit of installment lending to millions of retail locations in the U.S., while Upgrade Account is a mobile banking product offered to mainstream consumers.

Bridgit Inc.

Venture Round in 2020
Bridgit Inc. develops and provides construction-project management solutions. The company offers Bridgit Bench, a construction resource planning and workforce management tool; and Bridgit Field, an inspection, task, and communication management solution. It caters to contractors and developers. Bridgit Inc. was incorporated in 2014 and is headquartered in Kitchener, Canada.

Thrive Earlier Detection

Series B in 2020
Thrive is a healthcare company focused on saving lives by making earlier detection of cancer a routine part of medical care. It develops CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of the disease. CancerSEEK will serve as the core of Thrive’s integrated cancer information offering. The company was launched in 2019 by Third Rock Ventures, with funding from additional investors Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Camden Partners Nexus, Cowin Venture, Exact Sciences, and Gamma3.

Uhnder Inc.

Series C in 2020
Uhnder is a start-up developing products for sensing, cognition, and communication for the Internet of Things (IoT) market. It is headquartered in California with engineering and operations based in Austin and St. Louis. Uhnder develops a digital automotive radar-on-chip designed to automate systems for safety and better feedback response. Uhnder disrupts the autonomous vehicle business with what it says is a more accurate and reliable alternative to light detection and ranging, known as lidar, which is one of the most common technologies used to make vehicles more aware of their surroundings. Uhnder's chip helps to avoid collisions, alerts to potential problems, helps with quick localization, as electronic fences for navigation and localization and for communication.

ArcherDX

Series C in 2019
ArcherDX is advancing molecular pathology with a robust technology platform for genetic mutation detection by next-generation sequencing. By combining proprietary Anchored Multiplexed PCR (AMP™) chemistry in an easy-to-use, lyophilized format and powerful bioinformatics software, the Archer® platform dramatically enhances genetic mutation identification and discovery. ArcherDX provides oncology-focused research products and is pursuing regulatory approval for multiple companion diagnostic assays.

Agilis Biotherapeutics, LLC

Venture Round in 2017
Agilis Biotherapeutics develops DNA therapeutics for patients with rare diseases of the central nervous system (CNS) that single-gene defects cause. Its technology enables precise targeting and restoration of lost gene function while avoiding unintended off-target effects. Agilis Biotherapeutics also provides DNA therapeutics for patients with AADC Deficiency, a rare CNS disorder arising from reductions in the enzyme aromatic L-amino acid decarboxylase (AADC) that causes the inability to develop any motor strength and control resulting in breathing, feeding, and swallowing problems. Moreover, it offers DNA therapeutics for Friedreich’s Ataxia, a rare and life-shortening neurodegenerative disease caused by a single defect in the FXN gene, which causes reduced production of the frataxin protein, and DNA therapeutics for Angelman Syndrome (AS), a rare genetic, neurological disorder characterized by severe developmental delays. Agilis Biotherapeutics has a strategic partnership with Intrexon Corporation. It began its operation in 2013, with its headquarters in Lynnfield, Massachusetts.

Firefly BioWorks, Inc.

Venture Round in 2011
Firefly BioWorks, Inc. (Cambridge, MA) is introducing an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation. The company's core technology, Optical Liquid Stamping, was developed in the Chemical Engineering Department at MIT (News - Alert) by Firefly co-founders. The method allows rapid and scalable synthesis of encoded, multi-functional particles for the quantification of biological function. The company's long-term vision is to provide research and clinical scientists with reliable and affordable solutions for the comprehensive monitoring of biological systems.

Scopely

Series B in 2016
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

AppDynamics

Series F in 2015
Application performance management services and mobile analytics

Papercup

Funding Round in 2020
Papercup develops a software which automatically translates voice track in videos based on the combinations of bayesian neural networks and speech synthesis. The software helps the video creators to produce a video in their original language and any user can translate that video in their preferred language. The company is based in London, United Kingdom.

WireWheel.io

Series B in 2021
WireWheel, Inc. develops a data privacy management platform that helps comply with data privacy and data protection regulations. The company’s platform complies with regulations, including the EU GDPR, Privacy Shield, PCI DSS, and HIPAA. Its products include privacy program management and subject rights request management. The company combines machine learning, data science, and cloud computing. WireWheel, Inc. was incorporated in 2016 and is based in Arlington, Virginia

Scopely

Series E in 2020
Scopely, Inc. develops mobile and tablet touchscreen-based games for casual and core gamers worldwide. It offers fleet command games; and game design, live, marketing, analytics, business development, advertising, and other services. Scopely, Inc. was founded in 2011 and is based in Culver City, California.

BrightFlag

Series B in 2020
Brightflag enables organizations to take control of their legal spend with AI-powered software that’s easy to use and backed by proactive customer support. Brightflag processes billions of dollars of legal spend annually on behalf of its customers, resulting in hundreds of millions of dollars in savings and tens of thousands of hours in avoided administrative work. Founded in 2014, Brightflag serves a global community of in-house legal teams and their vendors from its offices in Dublin, New York, and Sydney.

AppDynamics

Series E in 2014
Application performance management services and mobile analytics

Candel

Series C in 2019
Candel develops cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.

Coagulo Medical Technologies

Venture Round in 2020
Coagulo Medical Technologies, Inc. develops testing systems that detects, identifies, and quantifies the effect of all anticoagulants in whole blood and communicates actionable results to healthcare providers. The company is based in Auburndale, Massachusetts.